Supplier profile
NOVARTIS FARMACEUTICA, S.A.
Every public-sector award we hold for this supplier, across Spain, from 3 Nov 2008 to 8 Oct 2026.
Awards won
1,163
all time
Attributed value
€1.5bn
209 shared, unvalued
Buyers
311
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Dirección Gerencia del Complejo Hospitalario Universitario de Canarias | 96 | €35.5m |
| Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín | 95 | €19.6m |
| Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil | 68 | €18.6m |
| Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria | 58 | €18.8m |
| Servicio Madrileno de Salud, Hospital Universitario La Paz | 25 | €23.8m |
| Gerencia de Servicio Sanitarios de Fuerteventura | 21 | €3.9m |
| Osakidetza | 20 | €40.1m |
| Inspección General de Sanidad de la Defensa | 19 | €2.2m |
| Dirección General de Planificación Económica | 17 | €42.1m |
| Consorci Sanitari Integral | 16 | €1.7m |
What they win
Awards
Showing 726–750 of 1,163 awards we hold
- Spain-Getafe: Various medicinal products ↗Hospital Universitario de Getafe€1.7mawarded 24 Dec 2020
- Spain-Vitoria-Gasteiz: Pharmaceutical products ↗Dirección General, Osakidetza€1.6mawarded 9 Dec 2020
- Spain-Barcelona: Pharmaceutical products ↗Hospital Clínic de Barcelonashared awardawarded 4 Dec 2020
- Suministro de varios medicamentos exclusivos para la G.A.I. de Villarrobledo-61031300AB20SUM00002 ↗Gerencia de Atención Integrada de Villarrobledo€970kawarded 3 Dec 2020
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileño de la Salud, Hospital Universitario Ramón y Cajal€1.1mawarded 2 Dec 2020
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileño de la Salud, Hospital Universitario Ramón y Cajal€1.6mawarded 2 Dec 2020
- Spain-Puerto del Rosario: Various medicinal products ↗Gerencia de Servicios Sanitarios de Fuerteventurashared awardawarded 2 Dec 2020
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileño de la Salud, Hospital Universitario Ramón y Cajal€681kawarded 2 Dec 2020
- Acuerdo Marco de Homologación de especialidades farmacéuticas basadas en principios activos y/o presentaciones de comercialización exclusiva para instituciones del Servicio Aragonés de Salud ↗Servicio Aragonés de Salud (SALUD)€37.4mawarded 30 Nov 2020
- Spain-Vitoria-Gasteiz: Pharmaceutical products ↗Dirección General — Osakidetza€233kawarded 24 Nov 2020
- Spain-Vitoria-Gasteiz: Pharmaceutical products ↗Dirección General — Osakidetza€1.9mawarded 24 Nov 2020
- Suministro de medicamentos cuyo principio activo es Octreotida, con destino a los hospitales del Complejo Asistencia de Zamora (Gerencia de Asistencia Sanitaria de Zamora ↗Gerencia de Asistencia Sanitaria de Zamora€157kawarded 19 Nov 2020
- Spain-Barcelona: Pharmaceutical products ↗Instituto Catalán de la Salut (ICS) — Centro Corporativoshared awardawarded 13 Nov 2020
- Spain-Leganés: Ophthalmologicals ↗Hospital Universitario Severo Ochoa (Servicio Madrileño de Salud)shared awardawarded 11 Nov 2020
- Spain-Madrid: Pharmaceutical products ↗Hospital Clínico San Carlos de Madrid€591kawarded 11 Nov 2020
- Spain-Barcelona: Pharmaceutical products ↗Institut català de la Salutshared awardawarded 6 Nov 2020
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileno de Salud, Hospital Universitario La Pazshared awardawarded 2 Nov 2020
- Suministro Farmacéutico de los principios activos Ivacaftor 150 mg, Erenumab 140 mg y Erenumab 70 mg ↗Gerencia de Servicio Sanitarios de Fuerteventura€10kawarded 23 Oct 2020
- Spain-Hospitalet de Llobregat: Various medicinal products ↗Instituto Catalán de Oncologiashared awardawarded 9 Oct 2020
- Spain-Melilla: Pharmaceutical products ↗Gerencia de Atención Sanitaria de Melilla, Instituto Nacional de Gestión Sanitaria€1.3mawarded 9 Oct 2020
- medicamentos: dabrafenib (tafinlar®) - nilotinib (tasigna®) - ranibizumab (lucentis ®) - ruxolitinib (jakavi®) y ribociclib (kisqali®) para los centros sanitarios dependientes del sespa ↗Servicio de Salud - Servicios Centrales€5.7mawarded 8 Oct 2020
- PNSP 3/2020 Suministro de Tisagenlecleucel para la Gerencia de Atención Integrada de Guadalajara-61034000GU20SUM00001 ↗Gerencia del Area de Atención Integrada de Guadalajara€320kawarded 8 Oct 2020
- Spain-Madrid: Medicinal products for sensory organs ↗Servicio Madrileño de Salud — Hospital Central de la Cruz Roja San José y Santa Adelashared awardawarded 7 Oct 2020
- Spain-Jaén: Various medicinal products ↗Servicio Andaluz de Salud — Hospital Universitario de Jaénshared awardawarded 25 Sept 2020
- Suministro de medicamentos eltrombopag, fingolimod, omalimumab, ranibizumab, ruxolotinib, secukinumab ↗Inspección General de Sanidad de la Defensa€240kawarded 25 Sept 2020
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.